Glenmark gets US FDA marketing nod for pravastatin tabs (PharmaBiz)
Glenmark Pharmaceuticals Ltd, a research-based company has received US FDA approval to market Pravastatin sodium oral tablets 10 mg, 20 mg and 40 mg, a generic version of Bristol Myers Squibb brand Pravachol that has annual sales of over USD 861 million.

Ranbaxy Receives Tentative FDA Approval for Fexofenadine Hydrochloride Tablets (RedNova)
PRINCETON, N.J., May 17 /PRNewswire/ -- Ranbaxy Pharmaceuticals Inc. (RPI), a wholly owned subsidiary of Ranbaxy Laboratories Limited (RLL), announced today that RLL has received tentative approval from the U.S.